Investor
Noting a spike in demand due to COVID-19, the company predicts that it will reach profitability by early 2021.
The arrangement comes alongside new eight-figure investments into the CGM maker, whose business looked to be in dire straits earlier this year.
The company's smart insulin pen, dubbed the InPen, is slated to become part of Medtronics diabetes portfolio.
The startup said its Care Pathway Management platform has so far been deployed among more than 70 health systems in 12 countries.
Cerner's investment into Xealth brings digital health prescription tools to its EHR & patient portal
The Providence-St. Joseph Health spin-out will receive $6 million from Cerner and LRVHealth.
The MobiHealthNews team breaks down the week's big digital health news: Teladoc's proposed $18 billion acquisition of Livongo.
Also: Dexcom continues to make strides, while iRhythm Technologies takes a hit in Q2.
The new round was led by European Bank for Reconstruction and Development and Health Capital.
The company said its services are accessible to millions of people through partnerships with over 200 employers, health plans and other strategic partners.
The deal is valued at roughly $4.7 billion.